Adeshwar Meditex Limited Stock

Equities

ADESHWAR

INE0H8J01015

Medical Equipment, Supplies & Distribution

Market Closed - Bombay S.E. 06:00:50 2024-05-15 am EDT 5-day change 1st Jan Change
29.45 INR +6.32% Intraday chart for Adeshwar Meditex Limited +6.32% -7.97%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2022 648M 7.78M Sales 2023 824M 9.89M Capitalization 242M 2.9M
Net income 2022 7M 84.08K Net income 2023 20M 240K EV / Sales 2022 0.88 x
Net Debt 2022 171M 2.05M Net Debt 2023 145M 1.74M EV / Sales 2023 0.47 x
P/E ratio 2022
50 x
P/E ratio 2023
11.7 x
Employees 36
Yield 2022 *
-
Yield 2023
-
Free-Float 13.23%
More Fundamentals * Assessed data
Dynamic Chart
Adeshwar Meditex Limited Announces the Resignation of Shivani Shivshankar Tiwari as Company Secretary and Compliance Officer CI
K. Nagaraja Rao and Abhinandan N cancelled the acquisition of 26% in Adeshwar Meditex Limited CI
Adeshwar Meditex Limited Announces Resignation of Sucheta Talati as Non-Executive, Non-Independent Director, Chairman of the Stakeholders Relationship Committee and Member of the Nomination & Remuneration Committee CI
K. Nagaraja Rao and Abhinandan N agreed to acquire 42.65% in Adeshwar Meditex Limited from Sucheta Sidharth Talati for INR40 million. CI
K. Nagaraja Rao and Abhinandan N made an offer to acquire 26% in Adeshwar Meditex Limited from INR80 million. CI
Adeshwar Meditex Limited Announces Board Appointments CI
Adeshwar Meditex Limited Approves Change in the Designation of Shailesh Vinayak Rajpure as Director CI
Adeshwar Meditex Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Adeshwar Meditex Limited Announces Board Resignations CI
Adeshwar Meditex Limited Approves the Appointment of Shailesh Vinayak Rajpure as an Additional Director CI
Adeshwar Meditex Limited Announces Demise of Siddharth Mulchand Talati, Managing Director CI
Adeshwar Meditex Limited Announces Resignation of Shailesh Vinayak Rajpure as Director CI
Adeshwar Meditex Limited Announces Change of Registered Office Address CI
Adeshwar Meditex Limited Approves Closure of Adeshwar Meditex Ltd-FZCO, Wholly Owned Subsidiary CI
Adeshwar Meditex Limited Appoints Shailesh Vinayak Rajpure as Additional Director CI
More news
1 day+6.32%
1 week+6.32%
Current month+6.32%
1 month-1.83%
3 months-5.00%
6 months+17.80%
Current year-7.97%
More quotes
1 week
29.45
Extreme 29.45
29.98
1 month
27.02
Extreme 27.02
29.98
Current year
25.18
Extreme 25.18
35.99
1 year
18.30
Extreme 18.3
36.00
3 years
16.20
Extreme 16.2
42.00
5 years
16.20
Extreme 16.2
42.00
10 years
16.20
Extreme 16.2
42.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 22-09-29
Director/Board Member 50 -
Corporate Officer/Principal - 15-07-06
Members of the board TitleAgeSince
Director/Board Member 55 97-12-31
Director/Board Member 50 -
Director/Board Member 74 17-03-23
More insiders
Date Price Change Volume

Delayed Quote Bombay S.E., May 15, 2024 at 06:00 am EDT

More quotes
Adeshwar Meditex Limited is an India-based manufacturer and exporter of sterile surgical wound dressings and medical disposables. The Company also does job-work for various multi-national companies. The Company's product categories include sterile wound dressings, combine dressing, gauze dressing and cotton products, medical bandages and plaster, antiseptics/disinfectants, and other products. Its sterile wound dressings products include Bactigauze, Petronet/Para heal, Bactigauze Plus, Nitro heal, Pividine Povitulle, Povizole, Framitulle, Fusitulle, Calginate-AG Silvinet, Hydrasoothe, Polybane, Polybane-N and antiseptic wound care. The Company's antiseptics/disinfectants products include BIODEX-C - 2.45%, BIO CLEAN, VILON-N VILON Concentrated, Pividine - 5 % (Topical Solution), Pividine-S - 7.5 %, (Scrub), Pividine-C - 10 %, LYSOL I.P., BENZ VETOL 3% and BID QUAT 10%.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. ADESHWAR Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW